Evidence map›Paper›PMID 40237044›Full record

ReviewRecent patents on anti-cancer drug discovery2026

Investigating the Therapeutic Potential and Molecular Mechanisms of Daphnetin: A Comprehensive Review.

Linyue Zhang, Jingwu Wu, Jinzhenwan Xue, Zhihong Jia, Xiaoni Zhou, Gang Hu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on anti-cancer drug discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Linyue ZhangNanchang University Queen Mary School, Nanchang, 330031, Jiangxi, China.
Jingwu WuSecond Clinical Medical College, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Jinzhenwan XueNanchang University Queen Mary School, Nanchang, 330031, Jiangxi, China.
Zhihong JiaDepartment of Pathology, the Second People's Hospital of Jingdezhen, Jingdezhen, Jiangxi, 333000, China.
Xiaoni ZhouDepartment of Obstetrics & Gynecology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.ORCID 0000-0001-5896-3801
Gang HuSchool of Life Sciences, Nanchang University, Nanchang, 330031, China.ORCID 0000-0002-4252-9151

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coumarins, a ubiquitous class of aromatic compounds present in a broad spectrum of organisms, including bacteria, fungi, and over 150 plant species, have been extensively studied over the years. Researchers have isolated and characterized more than 1,300 natural coumarins, many of which exhibit promising biomedical properties. Among these, daphnetin has emerged as a distinctive coumarin derivative that is characterized by its unique structural features to impart special physicochemical attributes. Daphnetin is renowned for its diverse range of biological activities, encompassing anticancer, anti-inflammatory, and antiallergic effects. These activities can be attributed to its ability to regulate specific molecular pathways within the body, making it a highly attractive compound for pharmacological research. Consequently, daphnetin has garnered considerable attention within the scientific community, specifically prompting an extensive investigation into its therapeutic potential across diverse clinical conditions. In this comprehensive review, we delved into the structure and sources of daphnetin, with a focus on its unique characteristics that underscore its potential as a therapeutic agent. We further explored the therapeutic potential of daphnetin, highlighting its multifaceted biological activities and the underlying molecular mechanisms. In addition, we scrutinized the potentially toxic effects of daphnetin in light of the current research status and prospects in this direction. By emphasizing the clinical significance of daphnetin, we aim to contribute to the ongoing endeavors toward the development of innovative and efficacious therapeutic strategies for an array of diseases.

Indexed as

Antineoplastic Agents, PhytogenicNeoplasmsUmbelliferonesAnimalsAnti-Inflammatory AgentsHumansAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicdaphnetinUmbelliferonesAlzheimer's diseaseautoimmune diseasecancerDaphnetindrug toxicityosteoporosispulmonary disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.